Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study
暂无分享,去创建一个
W. Novotny | P. Marlton | S. Opat | C. Tam | J. Burger | J. Trotman | J. Stern | E. Verner | R. Prathikanti | D. Simpson | J. Muñoz | P. Johnston | Jane E. Huang | K. Wu | G. Cull | D. Gottlieb